INTS logo

Intensity Therapeutics (INTS) Cash From Operations

Annual CFO

-$7.21 M
-$1.73 M-31.55%

December 31, 2023


Summary


Performance

INTS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINTScash flowmetrics:

Quarterly CFO

-$3.97 M
+$242.00 K+5.74%

September 30, 2024


Summary


Performance

INTS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINTScash flowmetrics:

TTM CFO

-$13.50 M
+$1.15 M+7.83%

September 30, 2024


Summary


Performance

INTS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINTScash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

INTS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.6%0.0%0.0%
3 y3 years-34.2%-340.8%-175.8%
5 y5 years-63.1%-340.8%-175.8%

INTS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.6%at low-1561.9%+22.4%-255.2%+7.8%
5 y5-year-63.1%at low-1561.9%+22.4%-1021.6%+7.8%
alltimeall time-63.1%at low-1561.9%+22.4%-1021.6%+7.8%

Intensity Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.97 M(-5.7%)
-$13.50 M(-7.8%)
Jun 2024
-
-$4.21 M(-3.5%)
-$14.64 M(+37.3%)
Mar 2024
-
-$4.37 M(+361.5%)
-$10.67 M(+48.1%)
Dec 2023
-$7.21 M(+31.6%)
-$946.00 K(-81.5%)
-$7.21 M(-8.7%)
Sep 2023
-
-$5.12 M(+2041.8%)
-$7.89 M(+107.7%)
Jun 2023
-
-$239.00 K(-73.5%)
-$3.80 M(-22.4%)
Mar 2023
-
-$901.00 K(-44.9%)
-$4.89 M(-10.6%)
Dec 2022
-$5.48 M
-$1.63 M(+59.3%)
-$5.48 M(-18.4%)
Sep 2022
-
-$1.03 M(-23.1%)
-$6.71 M(-6.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$1.33 M(-10.2%)
-$7.18 M(+1.1%)
Mar 2022
-
-$1.48 M(-48.3%)
-$7.11 M(+4.1%)
Dec 2021
-$6.83 M(+27.1%)
-
-
Dec 2021
-
-$2.87 M(+91.5%)
-$6.83 M(+72.5%)
Sep 2021
-
-$1.50 M(+19.2%)
-$3.96 M(+60.9%)
Jun 2021
-
-$1.26 M(+4.4%)
-$2.46 M(+104.4%)
Mar 2021
-
-$1.20 M
-$1.20 M
Dec 2020
-$5.37 M(+21.6%)
-
-
Dec 2019
-$4.42 M
-
-

FAQ

  • What is Intensity Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Intensity Therapeutics?
  • What is Intensity Therapeutics annual CFO year-on-year change?
  • What is Intensity Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Intensity Therapeutics?
  • What is Intensity Therapeutics quarterly CFO year-on-year change?
  • What is Intensity Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Intensity Therapeutics?
  • What is Intensity Therapeutics TTM CFO year-on-year change?

What is Intensity Therapeutics annual cash flow from operations?

The current annual CFO of INTS is -$7.21 M

What is the all time high annual CFO for Intensity Therapeutics?

Intensity Therapeutics all-time high annual cash flow from operations is -$4.42 M

What is Intensity Therapeutics annual CFO year-on-year change?

Over the past year, INTS annual cash flow from operations has changed by -$1.73 M (-31.55%)

What is Intensity Therapeutics quarterly cash flow from operations?

The current quarterly CFO of INTS is -$3.97 M

What is the all time high quarterly CFO for Intensity Therapeutics?

Intensity Therapeutics all-time high quarterly cash flow from operations is -$239.00 K

What is Intensity Therapeutics quarterly CFO year-on-year change?

Over the past year, INTS quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Intensity Therapeutics TTM cash flow from operations?

The current TTM CFO of INTS is -$13.50 M

What is the all time high TTM CFO for Intensity Therapeutics?

Intensity Therapeutics all-time high TTM cash flow from operations is -$1.20 M

What is Intensity Therapeutics TTM CFO year-on-year change?

Over the past year, INTS TTM cash flow from operations has changed by $0.00 (0.00%)